Buyer for rare disease CRO in Europe

Company to buy

Size: Medium business
Sales: 10 – 50 million EUR
Location: Europe
Reason for acquisition: The management wants to expand their business in Europe
#CFIE PHB243

Overview of buyer for rare disease CRO in Europe

This is a leading global contract research organization (CRO) that helps biotechnology and pharmaceutical companies design, manage, and execute clinical trials around the world.

Profile (strategy) of buyer for rare disease CRO in Europe

Primarily, this organization was built on the belief that personalized attention unlocks research’s full potential. Essentially, it guides pharmaceutical and biotechnology giants through the intricate maze of clinical trial development, management, and implementation.

With a team spanning over 3,000 scientists, clinicians, and research experts across more than 60 countries offers a comprehensive suite of services, encompassing the entire spectrum of clinical development. From initial study design and meticulous protocol development to patient recruitment and rigorous data analysis, their expertise transcends geographical boundaries. Thus, providing unparalleled support tailored to each treatment’s unique needs.

Overall, innovation fuels their dedication. Cutting-edge platforms and digital solutions streamline processes, enhance data accuracy, and improve communication between stakeholders. Consequently, this translates to faster trials, reduced costs, and ultimately, quicker access to life-saving treatments.

Notably, their influence extends beyond research and development. They actively shape the future of clinical trials, participating in industry-wide initiatives that promote ethical standards, patient safety, and research transparency. Further, their unwavering commitment to responsible conduct reflects their core values and solidifies their position as a leader in the CRO landscape.

Subscribe as an interested seller
Contact us to get details about this buyer for rare diseases CRO in Europe

Activities and products of suitable targets

Currently, the company is seeking a CRO specializing in rare diseases. Ideally, the acquisition of a company with experience in related areas would be a strategic opportunity for the company. As a result, the company could expand its range of services and become an even more important player in the European market.

Highlights

Over 3,000 experts in 60+ countries offer comprehensive clinical development services
Streamlined processes, accurate data, and improved communication through cutting-edge solutions
Strong client partnerships and meticulous tailoring of studies for each treatment

More information on this buyer for rare disease CRO in Europe

Please get in touch if you are interested in learning more about this buyer for rare disease CRO in Europe. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this CRO buyer

Please use a company e-mail address. No Hotmail/Yahoo/Googlemail etc.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a real opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy, and fit with the target. There is also a possibility that your details will be kept on file, and we will get back to you once there is an opportunity to do a transaction. CFIE cannot guarantee you will receive an answer to your request.